Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

Markets & Finance

CS First Boston Cuts Applera-Celera to 'Hold'

Credit Suisse First Boston downgraded Applera-Celera Genomics (CRA) to hold from buy.

Analyst Meirav Chovav says the announcement of major restructuring of Applera's online business and notes the company will receive a low to mid single digit royalty stream on new revenues generated by Knowledge Business after July 1. The arrangement transforms Applera from a current revenue generator into a very early stage drug discovery company, and that doing so reduces the current value of the company. Chovav sees a $1.77 fiscal 2002 (June) loss, and a $2.00 fiscal 2003 loss. He cut the $25 target to $20.

blog comments powered by Disqus